|
3476
|
5-NIdR
|
Potent inhibitor of translesion DNA synthesis (TLS) |
€120.00 |
|
3297
|
BChE inhibitor 8012-9656
|
Highly potent, selective and brain-penetrant BChE inhibitor |
€140.00 |
|
3393
|
CB096
|
Selective RAN inhibitor |
€110.00 |
|
3511
|
Cyproheptadine hydrochloride
|
5-HT2A and H1 antagonist |
€50.00 |
|
3459
|
Dacarbazine
|
DNA alkylating agent; antineoplastic agent |
€50.00 |
|
3503
|
Glipizide
|
KATP channel blocker; inhibits SUR1 |
€50.00 |
|
3501
|
Isradipine
|
Ca2+ channel antagonist |
€60.00 |
|
3495
|
Ivabradine hydrochloride
|
Selective sinus node I(f) channel inhibitor |
€50.00 |
|
3268
|
Metapristone
|
Metabolite of Mifepristone (Axon 1502); PI3K/AKT inhibitor |
€110.00 |
|
3490
|
Minoxidil
|
K+ channel opener (ATP sensitive, vascular) |
€50.00 |
|
3469
|
MS1943 trifluoroacetate
|
First-in-class EZH2 selective degrader; PROTAC |
€200.00 |
|
3498
|
Mycophenolate mofetil
|
Oral prodrug of MPA; Potent, selective, noncompetitive IMPDH inhibitor |
€60.00 |
|
3472
|
NMDA
|
Selective NMDA agonist |
€60.00 |
|
3505
|
Oxybutynin hydrochloride
|
Competitive M1/M2/M3 mAChR antagonist |
€50.00 |
|
3510
|
Phentolamine mesylate
|
Orally active α1- and α2 adrenoceptor antagonist |
€50.00 |
|
3269
|
PSB-KD107
|
Selective agonist for GPR18 |
€140.00 |
|
3507
|
Ranolazine
|
Ca2+/K+/Na+ channel blocker; Anti-anginal agent |
€70.00 |
|
3209
|
SBI-183
|
Orally active inhibitor of QSOX1 |
€110.00 |
|
3491
|
Stavudine
|
NRT inhibitor |
€60.00 |
|
3512
|
Terazosin hydrochloride
|
Selective, orally active α1 adrenoceptor antagonist |
€60.00 |